With the increasing demand for predictable and accountable Artificial Intelligence, the ability to explain or justify recommender systems results by specifying how items are suggested, or why they are relevant, has become a primary goal. However, current models do not explicitly represent the services and actors that the user might encounter during the overall interaction with an item, from its selection to its usage. Thus, they cannot assess their impact on the user's experience. To address this issue, we propose a novel justification approach that uses service models to (i) extract experience data from reviews concerning all the stages of interaction with items, at different granularity levels, and (ii) organize the justification of recommendations around those stages. In a user study, we compared our approach with baselines reflecting the state of the art in the justification of recommender systems results. The participants evaluated the Perceived User Awareness Support provided by our service-based justification models higher than the one offered by the baselines. Moreover, our models received higher Interface Adequacy and Satisfaction evaluations by users having different levels of Curiosity or low Need for Cognition (NfC). Differently, high NfC participants preferred a direct inspection of item reviews. These findings encourage the adoption of service models to justify recommender systems results but suggest the investigation of personalization strategies to suit diverse interaction needs.

目的：本研究评估了市售可解释的AI算法在增强临床医生在胸部X射线（CXR）上鉴定肺癌的能力的影响。设计：这项回顾性研究评估了11位临床医生在胸部X光片中检测肺癌的表现，并在有和没有市售的AI算法的帮助下（红点，观察到），预测CXRS可疑的肺癌。根据临床确定的诊断评估了临床医生的表现。设置：该研究分析了NHS医院的匿名患者数据；该数据集由成年患者（18岁及以上）的400张胸部X光片组成，他们在2020年进行了CXR，并提供相应的临床文本报告。参与者：由11位临床医生（放射科医生，放射科医生受训者和报告射线照相师）组成的读者小组参加。主要结果指标：临床医生在CXR上检测肺癌的总体准确性，敏感性，特异性和精度，有或没有AI输入。还评估了有或没有AI输入的临床医生与绩效标准偏差之间的协议率。结果：临床医生对AI算法的使用导致肺部肿瘤检测的总体性能提高，从而达到了在CXR上鉴定出的肺癌的总体增长17.4％ ，分别增加了13％和13％的阶段1和2期肺癌的检测，以及临床医生表现的标准化。结论：这项研究在AI算法的临床实用性方面表现出了巨大的希望，可以通过整体改善读者表现来改善早期肺癌诊断和促进健康平等，而不会影响下游成像资源。

深度学习（DL）模型为各种医学成像基准挑战提供了最先进的性能，包括脑肿瘤细分（BRATS）挑战。然而，局灶性病理多隔室分割（例如，肿瘤和病变子区）的任务特别具有挑战性，并且潜在的错误阻碍DL模型转化为临床工作流程。量化不确定形式的DL模型预测的可靠性，可以实现最不确定的地区的临床审查，从而建立信任并铺平临床翻译。最近，已经引入了许多不确定性估计方法，用于DL医学图像分割任务。开发指标评估和比较不确定性措施的表现将有助于最终用户制定更明智的决策。在本研究中，我们探索并评估在Brats 2019-2020任务期间开发的公制，以对不确定量化量化（Qu-Brats），并旨在评估和排列脑肿瘤多隔室分割的不确定性估计。该公制（1）奖励不确定性估计，对正确断言产生高置信度，以及在不正确的断言处分配低置信水平的估计数，（2）惩罚导致更高百分比的无关正确断言百分比的不确定性措施。我们进一步基准测试由14个独立参与的Qu-Brats 2020的分割不确定性，所有这些都参与了主要的Brats细分任务。总体而言，我们的研究结果证实了不确定性估计提供了分割算法的重要性和互补价值，因此突出了医学图像分析中不确定性量化的需求。我们的评估代码在HTTPS://github.com/ragmeh11/qu-brats公开提供。